RecruitingNCT06315556
Rare condition
Retinopathy of prematurity
16
studies recruiting now
as of 7 Sept 2026
190
studies registered in total
as of 7 Sept 2026
4
countries with a recruiting site
as of 7 Sept 2026
14 Jul 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT06612541
Point-of-Care Ophthalmic Diagnostic Imaging of Retinopathy of Prematurity
RecruitingNot applicableNCT06717412
Efficacy and Safety of Low-dose Conbercept for Retinopathy of Prematurity Therapy
RecruitingNCT07701759
Incidence of Hypoxia During Intravitreal Anti-VEGF (Vascular Endothelial Growth Factor) Injections for Retinopathy of Prematurity (ROP) Under Topical Anesthesia
RecruitingNot applicableNCT04995341
Retinal Microanatomy in Retinopathy of Prematurity (BabySTEPS2)
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 16 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Retinopathy of prematurity study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Retinopathy of prematurity
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the genes involved (LRP5, FZD4, NDP).
Treatments being studied
18 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 3Bevacizumab (Abevmy)
Phase 3Inositol
Phase 3Aflibercept (Eylea)
Phase 3Dexmedetomidine
Phase 3Ranibizumab (Byooviz)
Phase 3Sodium Chloride (Aqsia (balanced salt soln))
Phase 2/3Fasudil
Phase 2/3Propranolol
+ 10 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).